Studies implicate photoreceptor mitochondria as initiator in uveitis-associated vision loss

Article

Mitochondrial oxidative stress induced by translocation of inducible nitric oxide synthetase (iNOS) from the cytosol into the photoreceptor mitochondria appears to be a primary event leading to photoreceptor damage in experimental autoimmune uveitis (EAU), said Narsing A. Rao, MD, professor of ophthalmology, and director, ophthalmic pathology laboratory and uveitis service, University of Southern California, Los Angeles.

Mitochondrial oxidative stress induced by translocation of inducible nitric oxide synthetase (iNOS) from the cytosol into the photoreceptor mitochondria appears to be a primary event leading to photoreceptor damage in experimental autoimmune uveitis (EAU), said Narsing A. Rao, MD, professor of ophthalmology, and director, ophthalmic pathology laboratory and uveitis service, University of Southern California, Los Angeles.

"Epidemiologic studies show that complications of uveitis, particularly photoreceptor degeneration, are an important cause of vision loss," said Dr. Rao, who spoke during a symposium on mitochondrial oxidative stress in the visual system. "Based on previous investigations in EAU, the photoreceptor damage was thought to be caused by infiltrating macrophages releasing damaging oxidants.

"However, contradicting that dogma, we previously showed evidence that photoreceptor mitochondrial stress was present several days prior to infiltration of the phagocytic cells," Dr. Rao said. "Further studies now support the concept that the photoreceptor mitochondria are responsible for initiating the irreversible retinal damage occurring in EAU."

EAU, an animal model of uveitis that closely mimics the human disease, is created by immunizing Lewis rats with retinal soluble protein S-antigen. Dr. Rao described the findings from a series of EAU studies using wild type and iNOS knockout animals that were performed to characterize the cellular and molecular events occurring early after immunization.

Based on those experiments, Dr. Rao and colleagues proposed the following sequence to describe the pathway leading to photoreceptor damage in EAU.

"We believe that following immunization with the retinal antigen, a few activated T-cells infiltrate the retina where they induce expression of the TNF-alpha receptor and generate increases in TNF-alpha and other cytokines known to increase iNOS," Dr. Rao explained. "The upregulated iNOS subsequently translocates to the photoreceptor mitochondria and leads to mitochondrial oxidative stress and damage, including protein nitration, lipid peroxidation, and DNA damage, that ultimately culminates in photoreceptor cell apoptosis and vision loss."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.